Effects of melatonin on the mitogen-activated protein kinase signaling genes in hypoxic Leydig cells Authors: Mona Ghasemi, Adel Saberivand, Mohammadreza Gholami, Vahideh Assadollahi, Masoud Alasvand Published: 2024 ABSTRACT Leydig cells play a crucial role in male reproductive physiology, and their dysfunction is often associated with male infertility. Hypoxia negatively affects the structure and function of Leydig cells. This study aimed to investigate the impact of melatonin on the c-Jun N-terminal kinase (Jnk), P38, and extra-cellular signal-regulated kinases 1 and 2 (Erk1/2) mitogen-activated protein kinase (MAPK) signaling pathways in TM3 mouse Leydig cells under hypoxia induced by cobalt (II) chloride (CoCl2). The TM3 cell line was utilized as a subject of research, and 100 μM CoCl2 was employed to induce hypoxia. Following the addition of 10.00 ng mL-1 melatonin, quantitative reverse transcription-polymerase chain reaction and western blot analyses were conducted to assess the gene expression and protein level of Jnk, p38, and Erk1/2, while enzyme-linked immunosorbent assay was used to measure testosterone secretion. The results showed that melatonin significantly increased testosterone production in the CoCl2 + melatonin group compared to the CoCl2-treated group. Furthermore, melatonin elevated both the protein level and mRNA expression of Erk1/2, Jnk, and p38 genes in the CoCl2 + melatonin group compared to the CoCl2 group. In conclusion, melatonin activated the Jnk, p38, and Erk1/2 MAPK signaling pathways and enhanced testosterone production in the presence of CoCl2 in TM3 cells. Introduction Male fertility is primarily dependent on male reproductive processes, including testicular steroido-genesis, spermatogenesis, and sexual/erectile functions. However, these processes can be negatively impacted by various factors, including hypoxia.1 Hypoxia is a temporary or enduring reduction in the partial pressure of oxygen in the arteries, resulting in a decrease in oxygen delivery to the body's tissues.2 Hypoxia can generally be categorized as either environmental or pathological. Environmental hypoxia occurs when there is a low partial pressure of inhaled oxygen, often experienced at high altitudes, while pathological hypoxia refers to a compromised delivery of oxygen to cells and tissues due to a pathological condition, such as chronic pulmonary disease, sickle cell disease, and certain testicular pathologies, like varicocele and testicular torsion.3,4 The primary factor involved in the body's adaptation to low oxygen levels is hypoxia inducible factor (HIF).5 When oxygen levels are low, HIF, a protein existing as a heterodimer, attaches to the hypoxia response element6 to facilitate the activation of various genes being regulated by oxygen. Conflicting results exist on how hypoxia affects testosterone and gonadotropins. Some studies suggest that hypoxia may suppress testosterone, luteinizing hormone, and follicle stimulating hormone,7,8 while others indicate that intermittent hypoxia can increase testosterone synthesis in Leydig cells.9 Hypoxia harms spermato-genesis by reducing adenosine triphosphate production, leading to lower sperm production and quality, causing death and morphological changes in sperm cells, and hindering oxygen delivery to germ cells.10 It also inhibits germ cell proliferation and spermatogenic function. High-altitude-induced hypoxia is linked to lipid peroxidation, oxidative DNA damage, and reduced sperm quality and concentration.11 Low testosterone levels from hypoxia can reduce libido and sexual activity by affecting dopamine regulation12 and genital reflexes.13 Hypoxia-induced issues include reduced DNA methylation, and sperm count and motility, and increased DNA fragmentation.14 It can cause mitochondrial dysfunction and activate enzymes, like xanthine oxidase and inducible nitric oxide synthase, generating reactive oxygen species (ROS), leading to oxidative stress.2 Excess ROS-mediated oxidative stress, HIF-1α-mediated germ cell death and proliferation suppression, systemic inflammation, and epigenetic alterations are among the potential pathways implicated in hypoxia-induced male reproductive damage.6 Testosterone is essential in the male reproductive system as it promotes sperm maturation and maintains male secondary sex characteristics. Additionally, testosterone stimulates the function of reproductive organs, muscle protein synthesis, bone growth, calcium and phosphorus deposition, and red blood cells production. Research has linked androgen deficiency not only to male sexual dysfunction, erectile dysfunction, and reduced reproductive capacity but also to cardiovascular disease,15 diabetes,16 osteoporosis, and other diseases.17 The principal androgen-producing cells in mammals are Leydig cells. Located adjacent to the seminiferous tubules of the testis, Leydig cells are responsible for producing 95.00% of a man's testosterone.18 Steroido-genesis regulation is a multi-compartmental process involving numerous signaling pathways.19 A significant body of evidence suggests that distinct mitogen-activated protein kinase (MAPK) cascades play a role in steroidogenesis regulation through genetic and non-genomic influences.20,21 One of the most significant signaling pathways, the MAPK signaling pathway, is involved in cell proliferation and differentiation, apoptosis, stress, inflammatory responses, and response to environmental stimuli.22 The MAPK regulates cell proliferation, differentiation, and death in the mammalian testis and is considered an essential regulator of sperm development. The MAPK can indirectly influence animal germ cell development by affecting the function of Leydig cells.23 The signals mediated by extra-cellular signal-regulated kinases 1 and 2 (Erk1/2), c-Jun N-terminal kinase (Jnk), and p38 kinase, which are all capable of affecting steroidogenesis, are three downstream signal relays that the MAPKs can use to transmit growth factor signals to steroidogenic cells.21 N-acetyl-5-methoxytryptamine (melatonin), a neuro-hormone generated and secreted predominantly by the pineal gland, is essential for animal reproduction.24 Melatonin has been shown to protect the testis,25 sperm,26 and Leydig cells in males.27 Melatonin's role in male infertility has recently received a lot of interest. It has been demonstrated to play a role in male reproduction by altering steroid hormone secretion28 as well as spermatogenic cell proliferation.29 Melatonin has been shown to play a crucial protective and regulatory role in Leydig cells. Studies have shown that melatonin can decrease Leydig cells apoptosis, increase testosterone production, and improve the quality of sperms in melatonin-enriched transgenic mice.30 To the best of our knowledge, no study has been conducted to investigate the effect of melatonin on the expression of the primary genes p38, Jnk, and Erk1/2 in the MAPK signaling pathway in TM3 mouse Leydig cells under hypoxic conditions. In line with that, the present study was conducted to evaluate the effect of melatonin on mRNA expression and protein level of three MAPK genes, including Jnk, p38, and Erk1/2 subfamily, in TM3 mice Leydig cells under hypoxic conditions induced by cobalt (II) chloride (CoCl2). Materials and Methods Cell culture. The TM3 cells were cultured in 35.00 mm dishes using a 1:1 mixture of Ham-12 and Dulbecco’s MEM (Cytiva - HyClone, Logan, USA) included 5.00% horse serum (Gibco, Grand Island, USA) and 2.50% fetal bovine serum (Cytiva - HyClone). The culture media were replaced every two days. Cells were cultured at 37.00 ˚C in a humidified atmosphere containing 95.00% air and 5.00% CO2. After 12 hr of adherence, the dishes were divided into four groups, including no treatment, as well as treatments with 100 μM CoCl2,31 10.00 ng mL-1 melatonin,32 and 100μM CoCl2 plus 10.00 ng mL-1 melatonin, and incubated for 96 hr. The required concentrations of melatonin and CoCl2 were prepared by dissolving the powders of these substances in the culture medium. Cell supernatants were collected for testosterone concentration assay. Total cell protein and RNA were extracted for western blot and reverse transcription-polymerase chain reaction (RT-PCR) analyses, respectively. Each experiment was performed in triplicate. Testosterone concentration assay. The enzyme-linked immunosorbent assay kit (Monobind Inc., Lake Forest, USA) was used to measure testosterone concentrations in the medium samples using a chemi-luminescence immunoassay according to the manufacturer's instructions. The sensitivity of the testosterone assay was 0.576 pg. The results were expressed as ng mL-1. Real-time PCR analysis. For the real-time PCR analysis, total RNA was extracted using RNX TM reagent (CinnaGen, Tehran, Iran). After DNase-I treatment (CinnaGen), cDNA was generated from purified total RNA (2.00 µg) following the manufacturer's protocol (Takara, Kusatsu, Japan). Real-time PCR analyses were conducted using RunMei (Hunan Runmei Gene Technology Co., Hunan, China) in a final volume of 12.50 μL, containing 3.00 μL cDNA (100.00 ng), 0.25 μL of each primer (10.00 µM), 6.25 μL SYBR Green I PCR Master Mix (Yekta Tajhiz, Tehran, Iran), and 2.75 μL RNase-free water. The PCR conditions were as follows: 95.00 ˚C for 30 sec, 40 cycles of 95.00 ˚C for 5 min, with different melting temperature values for 34 sec, 95.00 ˚C for 15 sec, 60.00 ˚C for 60 sec, and 95.00 ˚C for 15 sec. The 2-ΔΔCT method was used to analyze the data, with β-actin serving as the reference gene. The primer sequences used are detailed in Table 1. Table 1Primer sequences of the genes used in the real-time polymerase chain reaction analysis of TM3 cells. Genes Accession number Primer sequence (5'→3') Product size (bp) P38 NM_001168508.1F: AGCAACCTAGCTGTGAACGAR: CACGGACCAAATATCCACTGTC168 Erk1/2 NM_011952.2F: AGCCCCAGAGATCATGCTTAR: AGGATAACACCACAGCTCCA159 Jnk NM_001310452.1F: AAGATCCCGGACAAGCAGTTR: CATTGCTGCACCTGTGCTAA149 β-actin NM_007393.5F: AAGAGCTATGAGCTGCCTGAR: CCACAGGATTCCATACCCAAGA105 Primer sequences of the genes used in the real-time polymerase chain reaction analysis of TM3 cells. Protein extraction and western blot analysis. Cellular proteins were extracted using a lysis buffer (Sigma-Aldrich, Taufkirchen, Germany) including 8.00 M urea, 2.00 M thiourea, and 10.00 mM Tris; pH: 8.00, and the Bradford method was employed to quantify the proteins colorimetrically. The proteins were separated by 12.00% sodium dodecyl-sulfate (Sigma-Aldrich) poly-acrylamide gel electrophoresis using the Laemmli method and then, electroblotted onto a nitrocellulose membrane using a semi-dry Trans-Blot device (Bio-Rad, Hercules, USA). The blots were briefly blocked with 5.00% skimmed milk, and incubated with primary antibodies against p38 (mouse monoclonal), β-actin (monoclonal), Erk1/2 (monoclonal), and Jnk (monoclonal) overnight at 4.00 ˚C, followed by treatment with a horseradish peroxidase-conjugated secondary antibody (1:5,000 v/v; Sigma-Aldrich) for 2 hr. Images were captured using the luminal system on a blot scanner (LiCor, Lincoln, USA). For quantification, β-actin was used as an internal normalizer.33 Statistical analysis. Statistical analysis was performed using GraphPad Prism (version 3.0; GraphPad Software Inc., San Diego, USA) via one-way analysis of variance. The data were expressed as mean ± standard error of the mean. The p < 0.05 was considered statistically significant. Results Effect of melatonin on testosterone production. Figure 1 shows the levels of testosterone concentration. Induced hypoxia with CoCl2 resulted in a significant decrease in testosterone production by TM3 cells compared to the control (p < 0.0001). The level of testosterone in cells treated with melatonin was significantly lower than that in the control (p = 0.0012). Simultaneous treatment of TM3 cells with 10.00 ng mL-1 of melatonin and 100 μM of CoCl2 caused a significant decrease in testosterone levels compared to the control group (p < 0.0001). It appears that the addition of melatonin resulted in a further increase in testosterone production in the induction of hypoxia with CoCl2 (simultaneous treatment group with melatonin and CoCl2 vs. CoCl2 alone group; p = 0.0005). Additionally, the amount of testosterone production in cells treated with melatonin was significantly higher than that in cells treated with CoCl2 (p < 0.0001). Furthermore, the secretion of testosterone in adjacent cells treated with melatonin was significantly higher than production of testosterone in cells treated with melatonin and CoCl2 (p = 0.0007). The testosterone concentrations in the hypoxic TM3 cells treated with melatonin (10.00 ng mL-1), Cobalt (II) chloride (CoCl2; 100 μM), and melatonin (10.00 ng mL-1) plus CoCl2 (100 μM) compared to the control group. Effect of melatonin on p38 , Jnk , and Erk1/2 mRNA expressions. As shown in Figure 2A, compared to the control, expression of p38 in the CoCl2, melatonin, melatonin + CoCl2 treated cells was increased about 3.60, 2.30, and 4.60-fold, respectively (p < 0.0001). However, the expression of p38 in the melatonin + CoCl2 group was increased compared to the CoCl2 alone group (p = 0.0002). Expression level of p38 was significantly higher in CoCl2-treated cells than melatonin-treated ones (p < 0.0001). While, the expression level of this gene in the group treated with melatonin + CoCl2 was significantly higher than the group treated with melatonin (p < 0.0001). The CoCl2 treatment induced about 1.80-fold up-regulation of Jnk (p = 0.0003), and treatments with melatonin and melatonin + CoCl2 caused respectively about 2.30- and 2.80-fold increases in the expression of Jnk gene compared to the control group (p < 0.0001). Also, the expression level of Jnk gene in the cells treated simultaneously with CoCl2 and melatonin was significantly higher than cells treated with CoCl2 alone (p = 0.0002). The expression of this gene in the group treated with melatonin was also higher than the CoCl2-treated group (p = 0.002). While, the expression of Jnk in the melatonin- treated group was lower than the melatonin + CoCl2-treated group (p = 0.0025; Fig. 2B). As shown in Figure 2C, the expression of Erk1/2 gene in the groups treated with CoCl2, melatonin, and melatonin + CoCl2 was increased respectively by 2.10 (p = 0.0005), 2.50 (p = 0.0002), and 3.40 (p < 0.0001) times compared to the control group. Also, compared to the CoCl2-treated group, the expression of this gene was increased significantly in the melatonin treated groups (p = 0.0201) and melatonin + CoCl2 (p = 0.0002). The expression of this gene in the group treated with melatonin alone was significantly decreased compared to the group treated with melatonin + CoCl2 (p = 0.0009). Effect of melatonin on p38 , Jnk , and Erk1/2 protein levels. As shown in Figures 3 and 4, western blot analysis revealed significantly higher level of p38 protein in TM3 cells treated with CoCl2 (p < 0.0001), melatonin (p = 0.0002), and CoCl2 + melatonin (p < 0.0001) compared to the control group. While, the p38 level in the melatonin-treated group was significantly lower than that in the CoCl2-treated group (p = 0.0008); its level in the group treated with melatonin + CoCl2 was significantly higher than that in the group treated with CoCl2 alone (p = 0.0006). Additionally, the level of p38 protein in the melatonin-treated group was significantly lower than that in the melatonin + CoCl2-treated group (p < 0.0001). Further western blot analysis revealed a significant elevation in Jnk level in CoCl2-treated (p = 0.0050), melatonin-treated (p = 0.0003), and CoCl2 + melatonin-treated (p < 0.0001) groups compared to the control. The level of Jnk in the melatonin-treated (p = 0.0038) and CoCl2 + melatonin-treated (p = 0.0002) groups significantly increased compared to the CoCl2-treated group. Additionally, western blot analysis showed that Jnk level in the melatonin-treated group alone was significantly decreased compared to the CoCl2 + melatonin group (p = 0.0032). The level of Erk1/2 in the CoCl2-treated (p = 0.0269), melatonin-treated (p = 0.0019), and CoCl2 + melatonin-treated groups significantly (p = 0.0008) increased compared to the control group. The level of Erk1/2 in the melatonin-treated and CoCl2 + melatonin-treated groups significantly (p < 0.02) increased compared to the CoCl2-treated group. Furthermore, the level of Erk1/2 showed a significant increase in TM3 cells treated with CoCl2 + melatonin compared to the melatonin-treated group. Effect of melatonin on the expression of mitogen-activated protein kinase signaling pathway-related genes in hypoxic TM3 cells. A) p38; B) C-Jun N-terminal kinase (Jnk); and C) Extra-cellular signal-regulated kinases 1 and 2 (Erk1/2). The relative protein levels of mitogen-activated protein kinase pathway-related proteins in hypoxic TM3 cells treated with 10.00 ng mL-1 melatonin. A) p38; B) C-Jun N-terminal kinase (Jnk); and C) Extra-cellular signal-regulated kinases 1 and 2 (Erk1/2). The acrylamide gel electrophoresis results for p38, Jnk, Erk1/2, and β-actin proteins. Discussion In this study, we evaluated the impact of melatonin on testosterone secretion from mouse Leydig cells (TM3 cell line), as well as the expressions of p38, Jnk, and Erk1/2 genes at both the mRNA and protein levels in the MAPK signaling pathway under hypoxic conditions induced by CoCl2 in vitro. The use of hypoxia models in cell culture has enabled the characterization of the hypoxia response and assessment of the effects of various chemicals and medications on hypoxia at cellular, biochemical, and molecular levels. Cobalt chloride-induced chemical hypoxia is one of the most commonly utilized models.34 Studies have shown that hypoxia induced by CoCl2 and its consequent up-regulation of HIF1 can lead to a decrease in testosterone production in mouse Leydig cells (TM3).8 Our current investigation revealed that testosterone synthesis in TM3 cells treated with CoCl2 was significantly lower compared to the control group, contrasting with the results reported by Hwang et al., in which hypoxia stimulated cell proliferation and testosterone release in Leydig cells.35 Melatonin administration has been shown to reduce the severity of testicular injury in animal models with hyperlipidemia, experimental gonadal torsion and varicocele, or toxicity caused by exogenous substances, such as anti-cancer medications or environmental toxins.36 Xu et al. found that 10.00 ng mL-1 melatonin stimulated proliferation while inhibiting apoptosis in Leydig cells.32 In the current study, testosterone release was significantly higher in cells being simultaneously treated with CoCl2 and 10.00 ng mL-1 melatonin than that in cells being only treated with CoCl2. Melatonin has been shown to directly influence testosterone release by binding to specific receptors.36 It has also been demonstrated to stimulate testosterone production in mammalian Leydig cells.19 In a recent review paper, Nikolaev et al., summarized the current knowledge regarding the membrane melatonin receptors (MT1 and MT2) activated cell signaling path-ways in physiology and pathology and their relevance to certain disease conditions, including cancer in humans.37 Today, it is believed that the site of melatonin's effect in the reproductive system includes several organs, such as the hypothalamus, pituitary gland, gonads, male and female reproductive organs, mammary glands, accessory sexual glands, or a combination of these organs. Melatonin plays an important role in several aspects of mammalian reproduction. This hormone can directly affect the function of ovaries and reproductive system, and may have a role in the pathophysiology of many reproductive problems. In this regard, the expressions of MT1 and MT2 receptors in many tissues or organs involved in reproduction support this point. Valenti et al. reported a dose-dependent suppression of testosterone release in the presence of melatonin in rat Leydig cells.38 However, rats given melatonin showed no discernible alterations in their serum testosterone levels. Despite the fact that in our investigation melatonin administration to Leydig cells considerably decreased testosterone secretion relative to the control group, testosterone secretion in the CoCl2-treated cells was significantly lower. A study found that treating Leydig cells with 10.00 ng/ml of melatonin lowers testosterone release by these cells, being consistent with the current findings.24 According to Frungieri et al., physiological levels of melatonin have a direct inhibitory effect on testosterone production in Leydig cells from reproductively active Syrian (golden) hamsters (Mesocricetus auratus).39 Numerous studies have revealed a link between the MAPK pathway and male reproductive health.40-43 The MAPKs are highly expressed and evolutionarily conserved proteins being essential for controlling signaling pathways and playing key roles in male reproductive processes in mammals. These proteins help transmit signals through phosphorylation cascades, regulating various intra-cellular functions, such as germ cell development in the male gonads, physiological maturation of spermatozoa in the epididymis, and regulation of motility during ejaculation in the female reproductive tract.44 The MAPK pathways consist of three pathways, including the p38, Jnk, and Erk pathways, playing important roles in spermatogenesis, as well as germ cell development, maturation, and apoptosis.8 It is know well known that the MAPK signaling plays an important role in regulating steroid synthesis. The Jnk and p38 signaling pathways are mostly associated with cell stress and inflammation, while the Erk signaling route is associated with cell proliferation and differentiation.45 Hypoxia has been shown to activate the Erk/Jnk/p38 MAPK signaling pathway.34,46 In this research, we initially measured MAPK pathway activation levels in the testis after induction of hypoxia by CoCl2 treatment. The results showed that hypoxia increased the expressions of p38, Jnk, and Erk, as well as the protein levels of p38, Jnk, and Erk, indicating that the MAPK pathway was activated in TM3 cells after exposure to CoCl2. The results also showed that melatonin significantly increased the levels of MAPKs-related proteins, as well as mRNA expressions of Erk and Jnk compared to the control group. However, the expression of p38 showed a significant decrease in both the protein and mRNA levels after treatment with melatonin compared to the CoCl2 group. In the group where TM3 cells were simultaneously treated with CoCl2 and melatonin, melatonin activated the MAPK pathway in Leydig cells in vitro by up-regulating the expression of key MAPK genes (p38, Jnk, and Erk) and proteins (p38, Jnk, and Erk). The HIF-1 activation requires p38 MAPK signaling, according to the literature.47 It has also been suggested that hypoxic stress increases the phosphorylation of both Erk1/2 and p38.48 Overall, these findings indicated that melatonin can activate the MAPK pathway in Leydig cells. Melatonin significantly increased the expressions of p38, Jnk, and Erk genes and proteins in accordance with the results published earlier.49-50 Additionally, a study has shown that melatonin can mitigate the effects of oxidative stress and inflammation by inhibiting the p38 pathway.47 Further-more, melatonin has been observed to reduce the phosphorylation levels of the MAPKs Erk and Jnk in hamster Leydig cells.31 It was shown that a decrease in the level of phosphorylated Erk1/2 down-regulates the steroid-related genes, inhibiting steroidogenesis in Leydig cells.40 Li et al., also revealed that nano-Tio2 may down-regulate ERK1/2/PKA/PKC signaling pathway, decreasing testosterone secretion in Leydig cells.42 These differences can be attributed to variations in melatonin dose and duration studied by the researchers, as well as differences in animal species and cell lines used in both in vivo and in vitro studies. In conclusion, supplementation of melatonin activated the Jnk, p38, and Erk1/2 MAPK signaling pathways in mRNA and protein stages and enhanced testosterone production in hypoxic Leydig cells line induced by CoCl2. Since the MAPK signaling pathway is a key player in connecting environmental stimuli, such as oxidative stress, hypoxia, and inflammation, understanding how this pathway interacts with these factors could offer valuable knowledge for improving treatments for male infertility. However, TM3 cells, being a specific cell line, may not fully represent the physiological responses of Leydig cells in vivo and results obtained from the present in vitro study may not translate accurately to in vivo conditions. Hence, more in vivo studies regarding the effects of melatonin on mRNA expression and protein level of the MAPK signaling genes under hypoxic conditions are suggested.